Safety and Efficacy of Risuteganib in Non Exudative Age-Related Macular Degeneration: Primary Results from a Phase 2 Study
To be presented by Peter K. Kaiser, M.D.
September 8: 9:30-9:36 AM
Palais des Congrès, Paris, France (Amphithéâtre Havane)
The Retina Society 2019 Annual Meeting
Safety and Efficacy of Risuteganib in Intermediate Non-exudative (Dry) Age-Related Macular Degeneration (AMD): Primary Results from a Phase 2 Study
To be presented by David S. Boyer, M.D.
September 12: 2:44-2:50 PM
The Landmark London, London, UK (Grand Ballroom)
Safety and Efficacy of a Novel Integrin Inhibitor ALG-1007 Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
To be presented by Eric Donnenfeld, M.D.
September 16: 9:48-9:54 AM
Paris Expo Porte de Versailles, Paris, France (Free Paper Forum: Podium 2)